Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | €150.00 | €241.54 | 61.029% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| iRhythm Technologies Inc | 11 | 0 | 1 | 0 | €91.00 | €123.46 | 35.666% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €96.00 | €109.94 | 14.525% |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | €98.00 | €103.07 | 5.174% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.28 | €100.00 | 48.633% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €68.38 | €100.00 | 46.242% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.65 | €100.00 | 19.546% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 1 | 0 | €40.66 | €95.00 | 133.645% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.56 | €80.00 | 13.379% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €60.50 | €79.55 | 31.495% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €38.98 | €70.00 | 79.579% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €69.00 | €69.00 | 0.000% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.20 | €68.78 | 209.817% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €61.00 | €66.53 | 9.064% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.37 | €63.93 | 17272.554% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.72 | €60.55 | 166.523% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €49.20 | €57.50 | 16.870% |
| Radnet Inc. | 8 | 3 | 1 | 0 | €51.50 | €52.20 | 1.361% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €39.60 | €50.00 | 26.263% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.40 | €50.00 | 26.904% |
| Staar Surgical Co. | 12 | 1 | 2 | 0 | €39.91 | €49.33 | 23.596% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |